Call for Abstract

2nd International Conference Neurooncology and Neurosurgery, will be organized around the theme “New Challenges and Latest Developments in Neuro Oncology and Treating Brain Tumour”

Neuro Oncology 2017 is comprised of 24 tracks and 196 sessions designed to offer comprehensive sessions that address current issues in Neuro Oncology 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Neurosurgery is the surgical speciality performed on the brain, spinal cord, nervous system and extra-cranial cerebrovascular system. Paediatric Neurosurgery deals with nervous system disorders and injuries of a child. Functional Neurosurgery treats central nervous system disorders and damages by Neurostimulation, Intrathecal drug delivery, Neuroablative therapies and many other newer techniques. Global Neurosurgery Market is expected grow at 11.7% CAGR by 2019. Global Interventional Neurology Market Is expected to reach $2,370.4 Million by the year 2020, expected to have a CAGR of 8.4% from 2015 to 2020. North America holds the largest share of neurovascular devices and surgical imaging market followed by Europe and Asia Pacific due to well acceptance of advanced devices among Neurosurgeons all over the world and it was $378.6 million in 2014.

  • Track 1-1Spinal Disc Herniation
  • Track 1-2Cervical and Lumbar spinal stenosis
  • Track 1-3Hydrocephalus
  • Track 1-4Head and Spinal Trauma
  • Track 1-5Traumatic injuries
  • Track 1-6Clinical Neurosurgery
  • Track 1-7Functional neurosurgery
  • Track 1-8Neurocritical Care

Cerebrovascular surgery involves operative treatment of neurovascular disorders of the brain and spine and surrounding blood vessels. The most common maladies treated by a cerebrovascular surgery include arteriovenous malformations, aneurysms and stroke. Globally 62 million people are suffering from cerebrovascular disease each year. CNS therapeutics comprises approximately 15% of total pharmaceutical sales which is around $30 billion.

  • Track 2-1Atherosclerosis
  • Track 2-2Aneurysms
  • Track 2-3Arteriovenous Malformations
  • Track 2-4Arteriovenous Fistulas
  • Track 2-5Cavernous Malformations
  • Track 2-6Developmental Venous Anomaly
  • Track 2-7Vascular Malformations of the Brain
  • Track 2-8Vascular Cognitive Impairment/ Vascular Dementia
  • Track 2-9Craniofacial Syndromes
  • Track 3-1Pediatric Brain and Spinal Tumors
  • Track 3-2Traumatic Brain and Spinal Injuries
  • Track 3-3Surgical Management
  • Track 3-4Spina Bifida
  • Track 3-5Pediatric Epilepsy
  • Track 3-6Skeletal Dysplasia
  • Track 3-7Craniosynostosis
  • Track 3-8Malformations of Brain and Spine
  • Track 3-9Vascular Abnormalities

Neurological Nursing is a nursing specialty dealing with assessment, nursing diagnosis and management of brain and nervous system disorders, tumors, brain injuries, trauma, spine injuries, stroke, seizures aneurysms and many more conditions.

Critical illness defines severe damage of vital organs like Central nervous system failure, brain damage, and spine injury and there is a chance of life threatening deterioration in the patient’s condition. Critical care is time dependent and delivered by physician to a critically injured patient and requires high complex decision to assess, monitor, manipulate and support vital organ function in order to treat vital organ system failure.

  • Track 4-1Neurology and Nursing
  • Track 4-2Brain Nursing
  • Track 4-3Mental Health Nursing
  • Track 4-4Addiction Nursing
  • Track 4-5Neuro Nurse Practise Guidence
  • Track 4-6Neurovascular Nursing
  • Track 4-7Geriatric Nursing
  • Track 4-8Pediatrics Nursing
  • Track 4-9Advance Nursing Practice

Neuro Oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst.

  • Track 5-1Antitumor Activity
  • Track 5-2Advances in Diagnostic test on Neuro Oncology
  • Track 5-3Central Nervous system Disorders
  • Track 5-4Types of pain in Neuro Oncology
  • Track 5-5Advanced MRI in Neuro Oncology
  • Track 5-6Advanced Biomarkers in Neuro Oncology
  • Track 5-7Pathophysiology in Neuro Oncology
  • Track 5-8Palliative care of Neuro Oncology
  • Track 5-9Brain Injury Rehabilitation
  • Track 5-10Latest advances in Neuro Oncology

Brain Cancer market is segmented on the basis of diagnosis and therapeutics. A brain cancer involves the growth of abnormal cells in the tissues of the brain. Primary brain cancer involves malignant tumor, Brain stem tumors, germ cell tumor, pituitary adenomas, Tumor development, DIPG, Cellular biology of brain cancer, primary CNS lymphomas, Pathophysiology and Risk factors of brain cancer and prognosis of brain tumors.

  • Track 6-1Brain Prognosis
  • Track 6-2Brain Tumour Surgery
  • Track 6-3Brain cancer awareness
  • Track 6-4Translational Research in Brain Tumors
  • Track 6-5Cancer Metablolism
  • Track 6-6Advanced Imaging of adult brain tumors
  • Track 6-7Epidermoid tumor
  • Track 7-1Germ cell tumor
  • Track 7-2Tumor development
  • Track 7-3CNS tumours
  • Track 7-4Malignant tumour
  • Track 7-5CNS Disorders
  • Track 7-6Immune Responses of the Nervous System
  • Track 7-7Primary CNS lymphomas
  • Track 7-8Neurological Disorders
  • Track 7-9Central Nervous system Cancers
  • Track 7-10Primary central nervous system lymphoma
  • Track 8-1Pituitary adenomas
  • Track 8-2Pineal tumors
  • Track 8-3Gigantism
  • Track 8-4Pituitary apoplexy
  • Track 8-5Clinically non-functioning pituitary adenoma
  • Track 8-6Prolactinoma
  • Track 8-7Thyrotropinoma
  • Track 8-8Craniopharyngioma
  • Track 8-9Acromegaly
  • Track 9-1Stem Cells
  • Track 9-2Brain Diagnosis
  • Track 9-3Brain Tumour
  • Track 9-4Spinal cord Injury
  • Track 9-5Spine tumors
  • Track 9-6Spinal Metastasis
  • Track 9-7Chordomas
  • Track 9-8Germinomas

Glioblastoma multiforme (GBM) (named as glioblastoma) is a invasive glioma which is developed from star-shaped glial cells (i.e. astrocytes and oligodendrocytes) that support the health of the nerve cells within the brain. Almost 1 in 5 tumors in the brain are glioblastoma.

  • Track 10-1Glioblastoma in Children
  • Track 10-2Olingodendrogliomas in adults
  • Track 10-3High–Grade & Low Grade Gliomas
  • Track 10-4Brainstem glioma
  • Track 10-5Ganglioglioma
  • Track 10-6Oligodendroglioma
  • Track 10-7Role of Gliomas in Neuro Oncology
  • Track 10-8Advances in treatment of Glioblastoma

When cancer develops elsewhere in the body and spreads (metastasizes) to the brain, which is called as secondary brain tumor, or metastatic brain cancer. Brain metastases (secondary brain tumors) occur in approximately 15% of cancer patients as a result of haematogenous dissemination of cancer, and the incidence may be rising because of better control of systemic disease. 

The overall annual incidence of primary brain tumors in the United States is 9.5 cases per 100,000 population. Over 60% of primary brain tumors are gliomas, and at least two-thirds of these are clinically aggressive and high grade. Brain tumors represent 20% of all childhood malignancies and are the number two cause of cancer death in children after leukaemia

  • Track 11-1Diffuse Intrinsic Pontine Glioma
  • Track 11-2Optic nerve glioma
  • Track 11-3Medulloblastoma
  • Track 11-4Malignant melanoma
  • Track 11-5Causes and Symptoms of metastatic tumors
  • Track 11-6Intracranial Metastasis
  • Track 11-7Tumour Heterogeneity
  • Track 11-8Inter- intra tumour heterogeneity

Angiogenesis is a vital process that facilitates tumor growth and survival. Angiogenesis is a well-controlled process that is regulated by angiogenic, growth, and survival factors that are secreted by the malignant cells as well as other cells within the tumor microenvironment

  • Track 12-1Tumor Angiogenesis
  • Track 12-2Brain Metastases
  • Track 12-3Diagnosis of Neuro Oncology
  • Track 12-4Current approaches of metastatic tumors
  • Track 12-5Targeted Therapy in Neuro Oncology
  • Track 12-6Biomarker Discovery
  • Track 12-7Structural brain and functional imaging
  • Track 12-8Angiogenesis inhibitors
  • Track 12-9Anti-angiogenic Therapies
  • Track 13-1Spine surgery
  • Track 13-2spine disorders
  • Track 13-3Astrocytoma
  • Track 13-4Ependymoma
  • Track 13-5Meningiomas
  • Track 13-6Schwannomas
  • Track 13-7Spine Therapy
  • Track 13-8Ependymoma

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It discloses findings in molecular and cellular radiation oncology, radiation technology, radiation physics, and clinical oncology.

  • Track 14-1Quality Measures of  Radiotherapy
  • Track 14-2Intensity modulated radiation therapy
  • Track 14-3Palliative radiotherapy in Neuro Oncology
  • Track 14-4Radiosensitizers
  • Track 14-5Cellular Radiation Oncology
  • Track 14-6Molecular Radiation Oncology
  • Track 14-7Radioactive compounds in NeuroImaging
  • Track 14-8Neuroradiology
  • Track 14-9Radioactive compounds in NeuroImaging
  • Track 14-10Radiation physics
  • Track 14-11Clinical Radiation Oncology

The primary method which is used in the initial diagnosis, monitoring of response, and process of progression in Neuro Oncology is neuroimaging techniques. Neuro imaging has enabled great progress in the diagnosis of brain cancer, as well as finding useful application in medical research and practice.

There are a number of accepted, safe imaging techniques in use today in research facilities and hospitals throughout the world which includes FMRI, CT scan, PET, EEG, MEG, NIRS. This session includes latest technologies and developments of Structural and functional imaging, Biomarker Discovery, Radioactive compounds in Neuroimaging, Computed tomography, Diffuse optical imaging, Magnetic resonance imaging, Positron emission tomography.

  • Track 15-1Neurobiology
  • Track 15-2Skull Metastasis
  • Track 15-3Computed tomography
  • Track 15-4Whole-genome analysis of gliomas 
  • Track 15-5Paediatric Neurosurgery
  • Track 15-6Soft tissue pain
  • Track 15-7Diffuse optical imaging
  • Track 15-8Magnetic resonance imaging
  • Track 15-9Positron emission tomography
  • Track 15-10Neurosurgical treatment in Neuro Oncology

Pediatric Neuro Oncology is a fast developing field. Brain tumors are the cause of cancer-related deaths among children. Brain disorders are the most common solid malignancy in children.  Their bodies and brains are still developing. Their tumors are different.  The common childhood brain cancers are not the same as the most common adult brain cancers. Though they are rare, brain tumors are very common form of solid tumors among children under the age of 15 and represent about 20% of all childhood cancers.

Childhood tumors frequently appear in different locations and behave differently than brain tumors appearing in adults.  Treatment options are different and can be strongly influenced by the age of the child.  Children suffering from brain cancer may also have a much better prognosis than adults with a similar condition. The common types of brain tumors in children are Neurofibromatosis, Primitive Neuroectodermal tumor, Leukaemia, Neuroblastoma, Medulloblastoma, Ependymoma and Astrocytoma.

  • Track 16-1Cancer Stem Cells
  • Track 16-2Pediatric Brain Tumor Models
  • Track 16-3Neurocutaneous Disorders
  • Track 16-4Neurofibromatosis
  • Track 16-5Medulloblastoma
  • Track 16-6Epigenetics in Pediatric Cancers
  • Track 16-7Proton Radiotherapy for Pediatric Brain Tumors
  • Track 16-8Anaplastic mixed glioma

The work of the neuropathologist consists largely of examining biopsy tissue from the brain and spinal cord to aid in diagnosis of disease. The biopsy is usually requested after a mass is detected by radiologic imaging. As for autopsies, the principal work of the neuropathologist is to help in the post-mortem diagnosis of various forms of dementia and other conditions that affect the central nervous system.

Neuropathology is the study of disease of nervous system tissue, usually in the form of either small surgical biopsies or whole autopsies. Neuropathology is a subspecialty of anatomic pathology, neurology, and neurosurgery.

  • Track 17-1Neuropathology of Brain Tumor
  • Track 17-2Clinical Neuropathology
  • Track 17-3Functional Neuroanatomy
  • Track 17-4Neuropathology of Neurodegenerative disorders
  • Track 17-5Treament and advancement in neuropathology
  • Track 17-6Molecular Pathology in Neuro Oncology
  • Track 17-7Neuropathology of Aging
  • Track 18-1cancer Immunotherapy
  • Track 18-2Vaccine therapy
  • Track 18-3behavioral/cognitive impairment
  • Track 18-4Neuropsychological Screen
  • Track 18-5Wisconsin Card Sorting Test
  • Track 18-6Comprehensive Neuropsychological Evaluation
  • Track 18-7Grooved Pegboard
  • Track 18-8Repeatable Battery of Neuropsychological Status
  • Track 18-9Astrocytoma

Neurosurgery is a complex surgical procedure that involves treatment, diagnosis, and rehabilitation of disorders affecting any region of the nervous system.

Some of the most common Neurosurgeries are skull base surgery, Image Guided Surgery, Laser Surgery ,  spinal Neurosurgery and  Neurosurgical treatment. The Global Neurosurgery market is expected to grow 11.71% over the period of 2014-2019.

  • Track 19-1Neurosurgery
  • Track 19-2Neuro imaging
  • Track 19-3Translational Therapeutics in Neuro Oncology
  • Track 19-4Image Guided Surgery
  • Track 19-5Laser Surgery
  • Track 19-6skull base surgery
  • Track 19-7CNS Neurosurgery
  • Track 19-8Stereotactic and Functional Neurosurgery
  • Track 19-9Tumour immunology
  • Track 19-10Clinical Neurosurgery

About one-third of patients are being treated for cancer pain, which leads to many different forms. It may be short-lived or long-lasting, mild or severe, or effect on few organs, bones or organ system. Since each patient’s pain is unique, it is determined that cancer pain management treatment plans must be adapt to address individual needs.

  • Track 20-1Neuroblastoma
  • Track 20-2Pain Management in Neuro Oncology
  • Track 20-3Pain-relieving therapies
  • Track 20-4Non-Drug Pain Treatment
  • Track 20-5Causes of Cancer Pain
  • Track 20-6Treating Cancer Pain
  • Track 20-7Nerve pain
  • Track 20-8Phantom pain
  • Track 21-1Brain cysts
  • Track 21-2Brain Tumor Microenvironment
  • Track 21-3Acoustic neuroma
  • Track 21-4Neuro Degenrative disorders
  • Track 22-1cancer Drugs
  • Track 22-2Chemotherapy
  • Track 22-3Genetic Heterogeneity in Neuro Oncology
  • Track 22-4Surgical mangement for brain tumors
  • Track 22-5Histamine Receptors
  • Track 22-6 Tuberomammillary nucleus

Brain cancer market is segmented on the basis of diagnosis and therapeutics.  Major research is going on targeted Therapies for Brain Cancer. On the basis of treatment the market is segmented into surgeries, radiation therapy, immunotherapy, chemotherapy, and targeted therapy. Therapeutic approaches include Chemotherapy Intensity modulated radiation therapy, palliative care, vaccine therapy, surgical delivery, Molecular pathology for clinician and challenges in therapy

  • Track 23-1Neuroimmunology
  • Track 23-2Drug compounds targeting Tumor metabolism
  • Track 23-3Gene therapy and virotherapy
  • Track 23-4Temozolomide
  • Track 23-5Anticancer drug discovery and development

Case report of Tumour heterogeneity are related in differences between tumours of the same type in different patients, and also difference between cancer cells within a tumour cells can show distinct  including cellular morphology, motility, gene expression, proliferation, metabolism, and metastatic potential. This process occurs both between tumours which is called as inter-tumour heterogeneity and within tumours called as intra-tumour heterogeneity. It plays a major role in brain Cancer.

  • Track 24-1Cancer cell biology
  • Track 24-2Clinical trials in cencer biology
  • Track 24-3Clinical trial design in Neuroscience
  • Track 24-4Clinical Oncology
  • Track 24-5Role of immunotherapy in GSCs
  • Track 24-6Antitumor Activity